Mice Model Services

Mice Model Services Market Outlook

The global Mice Model Services market is projected to reach approximately USD 3.1 billion by 2035, growing at a CAGR of about 8.5% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing prevalence of chronic diseases, the rising investment in research and development activities by pharmaceutical and biotechnology companies, and the growing demand for personalized medicine. Moreover, the advancements in genetic engineering and in-vivo pharmacology have further fueled the need for specialized mice model services. The ongoing efforts in drug discovery and regenerative medicine have also significantly contributed to the expansion of this market. The integration of innovative technologies in preclinical research is expected to streamline processes and enhance the efficiency of drug development, thus driving the market forward.

Growth Factor of the Market

The Mice Model Services market is experiencing a surge in growth due to several key factors. The increasing focus on precision medicine and the rising demand for tailored therapies are compelling drug developers to invest heavily in preclinical research, which is largely reliant on reliable animal models. Furthermore, the escalation of chronic diseases across the globe has necessitated the development of novel therapeutic options, directly impacting the demand for varied mice models in research. Additionally, the advent of cutting-edge technologies, such as CRISPR and advanced imaging techniques, has enhanced the capabilities of mice models, making them indispensable in drug discovery and efficacy testing. The alignment of regulatory frameworks encouraging the use of validated animal models in research is also vital in promoting the growth of this market. Furthermore, the collaboration between academic institutions and biotechnology firms has led to an innovative approach towards the utilization of mice models in research, further propelling market development.

Key Highlights of the Market

• The market is expected to grow at a CAGR of 8.5% from 2025 to 2035.
• Increased investment in R&D activities by pharmaceutical companies is a driving force.
• Technological advancements in genetic engineering are enhancing service capabilities.
• Regenerative medicine is creating new applications for mice model services.
• The COVID-19 pandemic has accelerated research in drug discovery, boosting demand for these services.

By Service Type

In-vivo Pharmacology Services:

In-vivo Pharmacology Services are crucial for understanding the pharmacokinetics and pharmacodynamics of drug candidates. These services encompass a range of studies designed to assess the efficacy and safety of new therapeutic compounds in living organisms, particularly mice. Given that mice share genetic, biological, and behavioral similarities to humans, they serve as an excellent model for preclinical testing. The demand for these services is primarily driven by the pharmaceutical industry's need to ensure that drug candidates are not only effective but also safe for human use before entering clinical trials. As more companies adopt in-vivo pharmacology testing as an integral part of their drug development pipeline, this segment is set to witness significant growth.

In-vivo Toxicology Services:

In-vivo Toxicology Services play a critical role in predicting the toxicity of compounds before they are tested in humans. These services evaluate adverse effects caused by chemical substances, enabling researchers to make informed decisions regarding the safety profiles of new drugs. The growing emphasis on regulatory compliance and the need for comprehensive safety data in drug development are propelling the need for these services. With increasingly stringent regulations around drug approval processes, pharmaceutical companies are prioritizing in-vivo toxicology studies to mitigate risks. This segment is increasingly important as it ensures that potentially harmful substances can be identified and eliminated early in the drug development process.

In-vivo Efficacy Testing Services:

In-vivo Efficacy Testing Services are essential for determining the therapeutic potential of new drugs. These services involve assessing the biological activity of drug candidates in living organisms, thereby providing critical insights into their effectiveness. The rising trend of personalized medicine mandates the necessity for robust efficacy testing in diverse genetic backgrounds, further enhancing the demand for these services. As drug developers aim to create targeted therapies that are tailored to specific patient populations, the reliance on in-vivo efficacy studies continues to grow. This segment is anticipated to flourish as new drugs transition from the laboratory to the clinic, requiring validation through rigorous testing.

In-vivo Genetic Engineering Services:

In-vivo Genetic Engineering Services involve the modification of genetic material within living organisms to create specific genetic alterations that can be used in research. This includes techniques such as CRISPR and gene knockout models. The increasing demand for genetically modified mice in research is driving this segment's growth. These services enable researchers to study the effects of specific genes on health and disease, offering invaluable insights into genetic functions. The rapid pace of advancements in genetic engineering technology has streamlined the creation of custom mouse models, allowing for more efficient and targeted studies. As personalized medicine becomes more prevalent, the need for precision in genetic engineering services is expected to remain high.

In-vivo Phenotyping Services:

In-vivo Phenotyping Services are crucial for understanding the physical and biochemical characteristics of genetically engineered mice. These services involve detailed assessments of the biological traits and behaviors of mice, allowing researchers to correlate genetic modifications with specific outcomes. The growing emphasis on functional genomics and the need for detailed biological characterization are key factors driving this market segment. As research becomes more focused on understanding complex disease mechanisms, the demand for comprehensive phenotyping services is set to rise. This segment is particularly important in the validation of new therapeutic targets and in the development of new treatment strategies.

By Application

Research & Development:

The Research & Development application of Mice Model Services is one of the largest segments within this market. As pharmaceutical companies and biotech firms prioritize R&D to innovate and create new therapies, the need for reliable animal models has surged. Mice are often used in early-stage drug discovery to assess biological activity and safety, making them indispensable in the R&D process. Furthermore, the increasing complexity of diseases requires extensive research, leading to a higher demand for diverse models to simulate human pathophysiology. With the ongoing race to discover new drugs and improve existing therapies, the R&D segment is expected to experience robust growth over the coming years.

Drug Discovery:

Drug Discovery is a critical phase in the development of new therapeutics and heavily relies on Mice Model Services for effective screening of potential drug candidates. Mice models are utilized in various stages of drug discovery, from initial lead identification to preclinical testing. As the landscape of drug development evolves, there is a growing focus on using innovative approaches, such as high-throughput screening in mice models, which further enhances their importance in this segment. The need for rapid and efficient drug discovery processes, especially in response to emerging health threats, is a significant driver of the demand for these services. This segment is poised to grow, fueled by ongoing advancements in drug discovery methodologies.

Regenerative Medicine:

Regenerative Medicine is an emerging field increasingly utilizing Mice Model Services to explore potential therapeutic interventions for various diseases. Mice are ideal models for studying the mechanisms of tissue regeneration and the development of stem cell therapies. The significant growth in regenerative medicine research is perpetuated by the need for effective solutions to conditions that currently lack viable treatments, such as neurodegenerative diseases, heart diseases, and injuries. As this sector continues to expand, the demand for tailored mice models to study regeneration processes will rise, leading to sustained growth in this application segment.

Toxicity Testing:

Toxicity Testing remains a vital application of Mice Model Services, as regulatory bodies require comprehensive safety evaluations of new compounds before they can be tested in humans. In-vivo models are critical for assessing the toxicological profiles of drugs, chemicals, and biologics. The increasing emphasis on patient safety and the need for thorough toxicity assessments are fueling demand in this segment. With the rising complexity of drug formulations and the regulatory landscape becoming more stringent, the need for reliable toxicity testing in preclinical studies continues to grow. This application segment is expected to thrive, driven by the imperative for thorough safety evaluations in drug development.

Other Applications:

Besides the primary applications, there are numerous other areas where Mice Model Services are utilized, including vaccine development, genetic research, and cancer studies. The broadening scope of biomedical research has led to the exploration of various applications for mice models, as they provide insights into a wide range of health conditions. This versatility contributes to the overall growth of the market as researchers increasingly recognize the benefits of using mice models for diverse experimental purposes. As new fields of study emerge, the demand for Mice Model Services in these other applications will likely expand, benefiting from increased investments in scientific research.

By User

Pharmaceutical & Biotechnology Companies:

Pharmaceutical and biotechnology companies are among the primary users of Mice Model Services, as they rely heavily on these models for preclinical research to validate their drug candidates. This user segment requires a variety of specialized services, including pharmacology, toxicology, and efficacy testing, to support their drug development pipelines. The growing trend towards personalized medicine is also driving these companies to adopt more diverse mice models that can mimic specific human conditions. With the increasing complexity of drug development and the rising investment in biotech innovations, this user segment is expected to witness significant growth in the coming years.

Contract Research Organizations:

Contract Research Organizations (CROs) provide essential support to pharmaceutical and biotechnology companies by offering specialized Mice Model Services. They conduct various preclinical studies, allowing their clients to focus on drug development while ensuring compliance with regulatory standards. The increasing reliance on outsourcing preclinical research and the need for expertise in specific areas have propelled the growth of CROs in this market. As the pharmaceutical industry expands its pipeline of drug candidates, the demand for CROs offering Mice Model Services is anticipated to increase significantly, marking a notable trend in the market.

Academic & Research Institutions:

Academic and research institutions play a crucial role in the Mice Model Services market, utilizing these models for fundamental research and experimental studies. These entities often explore the underlying mechanisms of diseases and the efficacy of potential treatments, making mice models integral to their work. With increased funding for biomedical research and a growing emphasis on translational research, academic institutions are expanding their use of Mice Model Services. This segment is expected to grow as educational and research opportunities further advance our understanding of health and disease, driving demand for sophisticated animal models.

Other End-users:

Other end-users of Mice Model Services include government research laboratories, non-profit organizations, and private research firms. These users employ mice models for various applications, including public health research and epidemiological studies. As research into public health issues continues to expand, the need for reliable mice models to simulate human diseases is becoming increasingly prominent. This diverse user base reflects the growing importance of Mice Model Services across various sectors, contributing to the overall expansion of the market and ensuring a steady demand from multiple avenues.

By Mice Type

Inbred Mice:

Inbred Mice are genetically homogenous and provide a stable genetic background, making them an ideal choice for research requiring consistency. These mice are extensively used for studying various genetic traits and conducting experiments aimed at understanding disease mechanisms. The predictability of their genetic profile ensures that experimental results are reproducible, which is crucial for scientific validation. As the need for reliable and replicable results in research grows, the demand for inbred mice models is expected to increase significantly in the coming years. This type of mouse plays a fundamental role in genetic studies, immunology, and drug testing.

Outbred Mice:

Outbred Mice, characterized by genetic diversity, are utilized in research to better represent human populations. Their genetic variability makes them suitable for studies that require an understanding of how different genetic backgrounds may affect disease outcomes and responses to treatments. The rising focus on personalized medicine and the need for models that closely mimic human heterogeneity are driving the demand for outbred mice services. As researchers explore the impact of genetic diversity on drug efficacy and safety, the significance of outbred mice in preclinical research is expected to grow, marking an important trend in the industry.

Genetically Engineered Mice:

Genetically Engineered Mice are pivotal in biomedical research, allowing scientists to study the effects of specific genes or modifications on health and disease. These mice can be tailored to exhibit particular traits or diseases, making them invaluable for investigating therapeutic targets. The rapid advancements in genetic engineering techniques, such as CRISPR, have accelerated the creation of genetically engineered mice, enhancing their role in drug discovery and development. As the complexity of human diseases is increasingly understood, the demand for genetically engineered mice to model these conditions is expected to rise, propelling market growth.

Hybrid/Congenic Mice:

Hybrid and Congenic Mice are important for understanding the interaction between genetic and environmental factors in research. These mice are bred to possess specific genetic traits while maintaining genetic diversity, making them suitable for various experimental designs. The ability to investigate gene-environment interactions enhances their utility in studying complex diseases. As research becomes more intricate and tailored, the demand for hybrid and congenic mice models is anticipated to grow, reflecting the evolving needs in preclinical research and drug development.

Spontaneous Mutant Mice:

Spontaneous Mutant Mice, which naturally occur with genetic variations, provide unique insights into the genetics of disease. Their unpredictable genetic traits offer researchers an opportunity to study the phenotypic outcomes of specific mutations. These models are particularly valuable in cancer research and studies related to inherited disorders. The growing interest in understanding the role of genetics in health and disease is driving the demand for spontaneous mutant mice. As such, this segment is likely to witness increased utilization in research settings, contributing to the broader scope of Mice Model Services.

By Region

The North American region is leading the global Mice Model Services market, accounting for a substantial share due to the presence of numerous pharmaceutical and biotechnology companies, alongside robust research institutions. The region's investment in R&D is complemented by a favorable regulatory environment that promotes innovation. Furthermore, the growing demand for personalized medicine and complex disease models is driving the market in North America. With a projected CAGR of 8.7%, this region is expected to maintain its dominance as more companies leverage advanced mice models for drug development and biomedical research.

Europe holds a significant position in the Mice Model Services market, contributing markedly to the overall growth of the sector. The European market is characterized by a strong emphasis on R&D within leading biotechnology firms and academic institutions. As the demand for high-quality preclinical research continues to rise, Europe is actively investing in innovative approaches, including the development of genetically engineered mice. The European market is expected to grow at a CAGR of 8.3%, driven by advancements in research technologies and the expansion of drug development pipelines across the region. The collaboration between academia and industry also plays a crucial role in strengthening the market position in Europe.

Opportunities

The Mice Model Services market is poised for significant opportunities driven by technological advancements and collaborative research initiatives. As researchers increasingly adopt advanced genetic engineering techniques, such as CRISPR, the potential for customized mice models tailored to specific research needs is expanding. This innovation facilitates a deeper understanding of disease mechanisms and the development of targeted therapies. Furthermore, the growing trend of personalized medicine is likely to lead to increased demand for diverse mouse models that can replicate human genetic variations. Collaborations between academic institutions, biotech companies, and research organizations are fostering an environment ripe for innovative approaches in drug discovery, opening new avenues for Mice Model Services. This cooperation is expected to result in the creation of novel models that can address complex health conditions, thereby driving market growth.

Additionally, the rising global focus on precision medicine creates an opportunity for Mice Model Services to provide tailored solutions that meet specific research requirements. As healthcare systems shift toward personalized treatment options, the demand for specialized mice models that can mimic patient-specific conditions will increase. This trend is particularly evident in oncology research, where the need for models that reflect patient heterogeneity is paramount. Moreover, the growing emphasis on reducing animal testing through the development of advanced in vitro models may present challenges, but it also drives innovation in creating more relevant and predictive animal models. By addressing these evolving research needs, the Mice Model Services market can capitalize on the expanding opportunities presented by advancements in biomedical research.

Threats

Despite the promising growth prospects, the Mice Model Services market faces several threats that could impact its trajectory. One of the primary challenges is the increasing scrutiny surrounding animal testing and the ethical considerations associated with using animal models in research. Regulatory bodies and advocacy groups are advocating for alternative methods, which could limit the utilization of traditional mice models. As researchers explore and adopt alternatives, the demand for conventional Mice Model Services may decline, posing a risk to the market. Additionally, the growing focus on in vitro testing and computational models could further threaten the reliance on animal models, potentially reshaping the landscape of biomedical research.

Another significant threat is the potential for supply chain disruptions, especially considering the global interconnectedness of research institutions, biotechnology companies, and suppliers. Any disruptions caused by geopolitical tensions, trade restrictions, or public health crises, as seen during the COVID-19 pandemic, can adversely affect the availability and cost of mice models and related services. Such fluctuations may hinder research timelines and increase operational costs for organizations relying on these services. To mitigate these threats, the Mice Model Services market must adapt by enhancing collaboration with regulatory bodies, investing in alternative research methods, and ensuring the resilience of supply chains.

Competitor Outlook

• Charles River Laboratories
• Envigo
• Jackson Laboratory
• Thermo Fisher Scientific
• Horizon Discovery
• WuXi AppTec
• Taconic Biosciences
• Covance
• GenOway
• Translational Genomics Research Institute (TGen)
• Eurofins Scientific
• Inotiv
• Charles River
• Harlan Laboratories
• The University of Chicago

The competitive landscape of the Mice Model Services market is characterized by a mix of established players and emerging companies that provide a wide range of services to pharmaceutical and biotechnology sectors. Major players such as Charles River Laboratories and Envigo dominate the market, leveraging their extensive experience and comprehensive service offerings to maintain a competitive edge. These companies invest heavily in research and development to enhance their service capabilities and expand their portfolio of mice models, ensuring they keep pace with the rapidly evolving needs of the industry. Moreover, partnerships and collaborations with academic institutions and research organizations are common strategies employed by these leaders to foster innovation and address specific research challenges.

In addition to the leading firms, several emerging players are entering the market, bringing innovative solutions and technologies to enhance Mice Model Services. For instance, companies like Horizon Discovery and WuXi AppTec focus on genetic engineering and custom model development, catering to the increasing demand for specialized mice models. These emerging companies often adopt a flexible approach, enabling them to quickly adapt to changing trends in biomedical research. The competitive environment encourages ongoing advancements in service delivery, ultimately benefiting researchers and drug developers seeking high-quality preclinical models.

Another notable aspect of the competitive landscape is the emphasis on sustainability and ethical practices in animal research. Firms that prioritize ethical sourcing and humane treatment of animals, as well as those that invest in developing alternative research methodologies, are likely to gain favor among clients facing increasing ethical scrutiny. For example, companies like GenOway focus on providing genetically engineered models while ensuring compliance with ethical standards. The ability to navigate the complexities of regulatory requirements while offering innovative solutions will be crucial for companies aiming to thrive in this evolving market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Envigo
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Inotiv
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Covance
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 GenOway
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 WuXi AppTec
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Charles River
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Horizon Discovery
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Jackson Laboratory
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Eurofins Scientific
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Harlan Laboratories
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Taconic Biosciences
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Thermo Fisher Scientific
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 The University of Chicago
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Charles River Laboratories
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Translational Genomics Research Institute (TGen)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Mice Model Services Market, By user
    • 6.1.1 Pharmaceutical & Biotechnology Companies
    • 6.1.2 Contract Research Organizations
    • 6.1.3 Academic & Research Institutions
    • 6.1.4 Other End-users
  • 6.2 Mice Model Services Market, By Mice Type
    • 6.2.1 Inbred Mice
    • 6.2.2 Outbred Mice
    • 6.2.3 Genetically Engineered Mice
    • 6.2.4 Hybrid/Congenic Mice
    • 6.2.5 Spontaneous Mutant Mice
  • 6.3 Mice Model Services Market, By Application
    • 6.3.1 Research & Development
    • 6.3.2 Drug Discovery
    • 6.3.3 Regenerative Medicine
    • 6.3.4 Toxicity Testing
    • 6.3.5 Other Applications
  • 6.4 Mice Model Services Market, By Service Type
    • 6.4.1 In-vivo Pharmacology Services
    • 6.4.2 In-vivo Toxicology Services
    • 6.4.3 In-vivo Efficacy Testing Services
    • 6.4.4 In-vivo Genetic Engineering Services
    • 6.4.5 In-vivo Phenotyping Services

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Mice Model Services Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Mice Model Services market is categorized based on

By Service Type

• In-vivo Pharmacology Services
• In-vivo Toxicology Services
• In-vivo Efficacy Testing Services
• In-vivo Genetic Engineering Services
• In-vivo Phenotyping Services

By Application

• Research & Development
• Drug Discovery
• Regenerative Medicine
• Toxicity Testing
• Other Applications

By user

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic & Research Institutions
• Other End-users

By Mice Type

• Inbred Mice
• Outbred Mice
• Genetically Engineered Mice
• Hybrid/Congenic Mice
• Spontaneous Mutant Mice

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Charles River Laboratories
• Envigo
• Jackson Laboratory
• Thermo Fisher Scientific
• Horizon Discovery
• WuXi AppTec
• Taconic Biosciences
• Covance
• GenOway
• Translational Genomics Research Institute (TGen)
• Eurofins Scientific
• Inotiv
• Charles River
• Harlan Laboratories
• The University of Chicago